{"id":"W2047013037","doi":"10.1017/s0317167100012105","title":"Monoclonal Antibodies and Progressive Multifocal Leukoencephalopathy","year":2011,"lang":"en","type":"review","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Canada","funders":"","keywords":"Progressive multifocal leukoencephalopathy; Natalizumab; Efalizumab; Medicine; Monoclonal antibody; Adalimumab; Rituximab; Adverse effect; Adverse Event Reporting System; Monoclonal; Pharmacovigilance; Infliximab; Internal medicine; Immunology; Antibody; Multiple sclerosis; Rheumatoid arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005275634,0.0008035539,0.00142123,0.005041751,0.0003679205,0.001035373,0.0007506172,0.001239648,0.003091133],"category_scores_gemma":[0.001330123,0.0002870563,0.0005930208,0.005711169,0.0006479927,0.001357574,0.0005610315,0.001044293,0.001520194],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007679079,"about_ca_system_score_gemma":0.001620707,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003097209,"about_ca_topic_score_gemma":0.005065922,"domain_scores_codex":[0.9996597,0.00005636545,0.00007552636,0.00004311114,0.0001321317,0.00003312397],"domain_scores_gemma":[0.9992918,0.0003134463,0.000213017,0.00001532349,0.0001243812,0.00004208292],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009358003,0.00008801676,0.001877083,0.03003122,0.0002024991,0.002636668,0.0001260067,0.0001912449,0.0007124767,0.001641225,0.03340188,0.9289982],"study_design_scores_gemma":[0.00005249826,0.0001183945,0.0107707,0.02257144,0.0005906516,0.0440179,0.0003150392,0.0001200722,0.0007885821,0.002631326,0.9179879,0.00003552525],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009796016,0.9993744,0.00001325807,0.00008629147,0.00004156769,0.000001479726,0.000004226621,0.000001578325,0.0003791578],"genre_scores_gemma":[0.001138368,0.9984105,0.00004319521,0.00007549891,0.00008195399,0.000002265653,0.00001093958,3.924572e-7,0.0002368807],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005041751,"threshold_uncertainty_score":0.01034087,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07475193843963476,"score_gpt":0.3321773307067408,"score_spread":0.257425392267106,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}